Hans Prenen Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON) University of Antwerp Biography Publications Institution JoVE Articles Hans Prenen has not added a biography. If you are Hans Prenen and would like to personalize this page please email our Author Liaison for assistance. Publications Humoral and Cellular Immune Responses Against SARS-CoV-2 After Third Dose BNT162b2 Following Double-dose Vaccination with BNT162b2 Versus ChAdOx1 in Cancer Patients Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2022 | Pubmed ID: 36341493 Prognostic Implications of Cellular Senescence in Resected Non-small Cell Lung Cancer Translational Lung Cancer Research. Aug, 2022 | Pubmed ID: 36090630 Ipilimumab- and Nivolumab-induced Myocarditis in a Patient with Metastatic Cholangiocarcinoma: a Case Report Journal of Medical Case Reports. Jul, 2022 | Pubmed ID: 35831829 Iron Supplementation is Sufficient to Rescue Skeletal Muscle Mass and Function in Cancer Cachexia EMBO Reports. Apr, 2022 | Pubmed ID: 35199910 Targeting Hedgehog Signaling in Pancreatic Ductal Adenocarcinoma Pharmacology & Therapeutics. Aug, 2022 | Pubmed ID: 34999181 Excellent Response to MEK Inhibition in an Gene Fusion Driven Carcinoma: Case Report and Literature Review Anticancer Research. Jan, 2022 | Pubmed ID: 34969747 Safety, Pharmacokinetics, and Efficacy of Budigalimab with Rovalpituzumab Tesirine in Patients with Small Cell Lung Cancer Cancer Treatment and Research Communications. 2021 | Pubmed ID: 34329846 Macrophage MiR-210 Induction and Metabolic Reprogramming in Response to Pathogen Interaction Boost Life-threatening Inflammation Science Advances. May, 2021 | Pubmed ID: 33962944 Immunoglobin G/total Antibody Testing for SARS-CoV-2: A Prospective Cohort Study of Ambulatory Patients and Health Care Workers in Two Belgian Oncology Units Comparing Three Commercial Tests European Journal of Cancer (Oxford, England : 1990). May, 2021 | Pubmed ID: 33773276 Cancer-Associated Fibroblasts As a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer Cancers. Feb, 2021 | Pubmed ID: 33673405 The Tele-transition of Toxicity Management in Routine Oncology Care During the Severe Acute Respiratory Syndrome (SARS-CoV-2) Pandemic British Journal of Cancer. Apr, 2021 | Pubmed ID: 33558713 Patient-derived Organoids As Individual Patient Models for Chemoradiation Response Prediction in Gastrointestinal Malignancies Critical Reviews in Oncology/hematology. Jan, 2021 | Pubmed ID: 33310278 RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies Frontiers in Genetics. 2020 | Pubmed ID: 33613616 High Mortality of Cancer Patients in Times of SARS-CoV-2: Do Not Generalize! European Journal of Cancer (Oxford, England : 1990). Oct, 2020 | Pubmed ID: 32927375 SARS-CoV-2 and Cancer: Are They Really Partners in Crime? Cancer Treatment Reviews. Sep, 2020 | Pubmed ID: 32731090 Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions Molecular Diagnosis & Therapy. Feb, 2020 | Pubmed ID: 31838654 The Potential and Controversy of Targeting STAT Family Members in Cancer Seminars in Cancer Biology. Feb, 2020 | Pubmed ID: 31605750 RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review International Journal of Molecular Sciences. May, 2019 | Pubmed ID: 31052546 Tumor-associated Macrophages: a Short Compendium Cellular and Molecular Life Sciences : CMLS. Apr, 2019 | Pubmed ID: 30747250 RANK/RANKL Signaling Inhibition May Improve the Effectiveness of Checkpoint Blockade in Cancer Treatment Critical Reviews in Oncology/hematology. Jan, 2019 | Pubmed ID: 30661662 Comparison of Multiple Protein Extraction Buffers for GeLC-MS/MS Proteomic Analysis of Liver and Colon Formalin-fixed, Paraffin-embedded Tissues Molecular BioSystems. Feb, 2016 | Pubmed ID: 26676081 Multiparametrische tumor organoïde drug screening met behulp van Widefield Live-Cell Imaging voor bulk en single-organoïde analyse Maxim Le Compte1, Edgar Cardenas De La Hoz2, Sofía Peeters1, Evelien Smits1, Filip Lardon1, Geert Roeyen1,3, Steve Vanlanduit2, Hans Prenen1,4, Marc Peeters1,4, Abraham Lin1,5, Christophe Deben1 1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2Industrial Vision Lab, University of Antwerp, 3Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA), 4Department of Oncology, University Hospital Antwerp (UZA), 5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp JoVE 64434 Cancer Research
Multiparametrische tumor organoïde drug screening met behulp van Widefield Live-Cell Imaging voor bulk en single-organoïde analyse Maxim Le Compte1, Edgar Cardenas De La Hoz2, Sofía Peeters1, Evelien Smits1, Filip Lardon1, Geert Roeyen1,3, Steve Vanlanduit2, Hans Prenen1,4, Marc Peeters1,4, Abraham Lin1,5, Christophe Deben1 1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2Industrial Vision Lab, University of Antwerp, 3Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA), 4Department of Oncology, University Hospital Antwerp (UZA), 5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp JoVE 64434 Cancer Research